Scott Gottlieb, a conservative health policy analyst and Trump's nominee for FDA commissioner, has promised to resign from the numerous drug company boards on which he sits. Still, should his nomination be ultimately approved, he will be a conflicted leader of an agency with a weakened oversight mandate.
↧